Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification

Clinical Chemistry

Volumn 43, Issue 5, 1997, Pages 752-758

  Gelmini, Stefania ^a   Orlando, Claudio ^a   Sestini, Roberta ^a   Vona, Giovanna ^a   Pinzani, Pamela ^a   Ruocco, Luca ^b   Pazzagli, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Perkin Elmer Italy   (Italy)

Author keywords

breast cancer; fluorescence assays; genetic alterations; oligonucleotide probes

Indexed keywords

6 CARBOXYFLUORESCEIN; BETA GLOBIN; DNA; ONCOPROTEIN; RHODAMINE;

ACCURACY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FLUORESCENCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OLIGONUCLEOTIDE PROBE; ONCOGENE C ERB; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY;

EID: 0030945827     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.5.752     Document Type: Article

References (33)

1. Kemp DJ, Smith DB, Foots J, Samaras N, Peterson MG. Colorimetric detection of specific DNA segments amplified by polymerase chain reaction. Proc Natl Acad Sci U S A 1989;86:2423-7.
2. Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A 1989;86:6230-4.
3. Lunderberg J, Wahlberg J, Uhlen M. Rapid colorimetric quantification of PCR-amplified DNA. BioTechniques 1991;10:68-75.
4. Musiani M, Zerbini M, Gibellini D, Gentiloni G, La Placa H, Ferri E, Girotti S. Chemiluminescent assay for the detection of viral and plasmid DNA using digoxigenin-labeled probes. Anal Biochem 1991;194:394-8.
5. Landgraf A, Reckmann B, Pingoud A. Quantitative analysis of polymerase chain reaction (PCR) products using primers labeled with biotin and a fluorescent dye. Anal Biochem 1991;193:231-5.
6. Hruza C, Dobianer K, Beck A, Czerwenka K, Hanak H, Klein M, et al. HER-2 and int-2 amplification estimated by quantitative PCR in paraffin embedded ovarian cancer tissue sample. Eur J Cancer 1993;29:1593-7.
7. Frye RA, Benz CC, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989;4:1153-7.
8. Sestini R, Orlando C, Zentilin L, Gelmini S, Pinzani P, Bianchi S, et al. Measuring c-erbB-2 amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem 1994;40:630-6.
9. Sestini R, Orlando C, Zentilin L, Lami D, Gelmini S, Pinzani P, et al. Measurement of gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc by quantitative PCR with a multiple competitor template. Clin Chem 1995;41:826-32.
10. Harlow SP, Stewart CC. Quantification of c-myc gene amplification by competitive PCR assay system. PCR Methods Appl 1983;3:163-8.
11. Lawyer FC, Stoffel S, Saiki RK, Myambo KB, Drummond R, Gelfand DH. Isolation, characterization and expression in Escherichia coli of the DNA polymerase gene from the extreme thermophile Thermus aquaticus. J Biol Chem 1989;264:6427-37.
12. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus. DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
13. Lyamichev V, Brow MAD, Dahlberg JE. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science 1993;260:778-83.
14. Lee LG, Connel CR, Bloch W. Allelic discrimination by nick translation PCR with fluorogenic probes. Nucleic Acid Res 1993;21:3761-6.
15. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ulrich A. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;253:177-82.
16. Slamon DJ, Godolphin W, Jone LA, Holt JA, Wong SG, Keit DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:702-12.
17. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Less AW, Jamil N, et al. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 1991;51:556-67.
18. Clark GM, McGuire WL. Follow up study of HER-2/neu amplification in primary breast cancer. Cancer Res 1991;51:944-8.
19. Perkin-Elmer. TaqMan probe design, synthesis and purification. Foster City. CA: Applied Biosystems, 1995.
20. Forster V Th. Zwischenmolekular energie-wanderung und fluoreszenz. Ann Phys (Leipzig) 1948;2:55-75.
21. Livak K, Flood SJA, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quencher probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 1995;4:357-62.
22. Impraim CC, Saiki RK, Erlich HE, Teplitz RL. Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridization with sequence-specific oligonucleotides. Biochem Biophys Res Commun 1987;142:710-6.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989:9-16.
24. Hynes NE, Geber HA, Saurer S, Groner B. Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem 1989;39:145-51.
25. Wolman SR, Pauley RJ, Mohamed AN, Dawson PJ, Visscher DW, Sarkar FH. Genetic markers as prognostic indicators in breast cancer. Cancer 1992;70:1765-74.
26. Borg A, Tandon AK, Siggurdsson H, Clark GM, Ferno M, Fuqua SAW, et al. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 1990;50:4332-7.
27. Lönn U, Lönn S, Nilsson B, Stenkvist B. Prognostic value of erbB-2 and myc amplification in breast cancer imprints. Cancer 1995;75:2681-7.
28. Perren T. c-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer 1991;63:328-32.
29. Ali IU, Campbell G, Lidereau R, Callahan R. Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma. Oncogene Res 1988;3:139-46.
30. Zhou DJ, Ahuja H, Cline MJ. Proto-oncogene abnormalities in human breast cancer: c-erbB-2 amplification does not correlate with recurrence of disease. Oncogene 1989;45:360-3.
31. Heintz NH, Leslie KO, Rogers LA, Howard PL. Amplification of the c-erbB-2 oncogene and prognosis of breast adenocarcinoma. Arch Pathol Lab Med 1990;114:160-3.
32. Thibodeau SN. Recent applications of PCR in clinical laboratory medicine [Editorial]. Clin Chem 1994;40:681-2.
33. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related protoncogene c-erbB-2 in human mammary cell lines by different molecular mechanisms. EMBO J 1987;6:605-10.